BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wehrhan F, Büttner-Herold M, Distel L, Ries J, Moebius P, Preidl R, Geppert CI, Neukam FW, Kesting M, Weber M. Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas. BMC Cancer 2018;18:823. [PMID: 30115022 DOI: 10.1186/s12885-018-4726-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Coppock JD, Mills AM, Stelow EB. Galectin-3 Expression in High-Risk HPV-Positive and Negative Head & Neck Squamous Cell Carcinomas and Regional Lymph Node Metastases. Head Neck Pathol 2021;15:163-8. [PMID: 32564273 DOI: 10.1007/s12105-020-01195-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Tokmak S, Arık D, Pınarbaşlı Ö, Gürbüz MK, Açıkalın MF. Evaluation and Prognostic Significance of Galectin-3 Expression in Oral Squamous Cell Carcinoma. Ear Nose Throat J 2021;100:578S-83S. [PMID: 31838918 DOI: 10.1177/0145561319893861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kondoh N, Mizuno-Kamiya M, Umemura N, Takayama E, Kawaki H, Mitsudo K, Muramatsu Y, Sumitomo S. Immunomodulatory aspects in the progression and treatment of oral malignancy. Jpn Dent Sci Rev 2019;55:113-20. [PMID: 31660091 DOI: 10.1016/j.jdsr.2019.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
4 Friedman LA, Ring KL, Mills AM. LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy. Int J Gynecol Pathol 2020;39:203-12. [PMID: 32267656 DOI: 10.1097/PGP.0000000000000608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Shao Y, Song Y, Xu S, Li S, Zhou H. Expression Profile of Circular RNAs in Oral Squamous Cell Carcinoma. Front Oncol 2020;10:533616. [PMID: 33330021 DOI: 10.3389/fonc.2020.533616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zheng Y, Feng W, Wang YJ, Sun Y, Shi G, Yu Q. Galectins as potential emerging key targets in different types of leukemia. Eur J Pharmacol 2019;844:73-8. [PMID: 30452910 DOI: 10.1016/j.ejphar.2018.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]